The role of mhc polymorphism in anti-microbial resistance

Microbes and Infection

Volumn 6, Issue 5, 2004, Pages 501-512

  Nikolich Žugich, Janko ^a   Fremont, Daved H ^b   Miley, Michael J ^b   Messaoudi, Ilhem ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Bm; CDR regions; Complementarity determining region of the TCR; CTL; Cytotoxic T lymphocytes; Dm; Immunity; MHC; Mhc mutation arising in the murine H 2b haplotype; Pathogen resistance; T cell receptor

Indexed keywords

ANTIINFECTIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE FRAGMENT; T LYMPHOCYTE RECEPTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; AUTOIMMUNE DISEASE; CELL MATURATION; CELL SURVIVAL; CHICKEN; CRYSTAL STRUCTURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EGG; GENETIC CODE; GENETIC POLYMORPHISM; HISTORY; HUMAN; IMMUNITY; INFECTION SENSITIVITY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; THYMUS;

MURINAE;

EID: 1942517330     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.01.006     Document Type: Short Survey

References (83)

1. McDevitt H.O. Discovering the role of the major histocompatibility complex in the immune response. Annu. Rev. Immunol. 18:2000;1-17.
2. Snell G.D. The H-2 locus of the mouse: observations and speculations concerning its comparative genetics and its polymorphism. Folia Biol. (Praha). 14:1968;335-358.
3. Dausset J. The HLA adventure. Transplant. Proc. 31:1999;22-24.
4. Benacerraf B., Germain R.N. The immune response genes of the major histocompatibility complex. Immunol. Rev. 38:1978;70-119.
5. Zinkernagel R.M., Doherty P.C. The discovery of MHC restriction. Immunol. Today. 18:1997;14-17.
6. Fink P.J., Bevan M.J. Positive selection of thymocytes. Adv. Immunol. 59:1995;99-133.
7. Grey H.M., Buus S., Colon S., Miles C., Sette A. Structural requirements and biological significance of interactions between peptides and the major histocompatibility complex. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 323:1989;545-552.
8. Kisielow P., Bluthmann H., Staerz U.D., Steinmetz M., von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 333:1988;742-746.
9. Townsend A.R., McMichael A.J. Specificity of cytotoxic T lymphocytes stimulated with influenza virus. Studies in mice and humans. Prog. Allergy. 36:1985;10-43.
10. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403-450.
11. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:1995;587-622.
12. Rammensee H.G., Friede T., Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:1995;178-228.
13. Davis M.M., Chien Y.H., Gascoigne N.R., Hedrick S.M. A murine T cell receptor gene complex: isolation, structure and rearrangement. Immunol. Rev. 81:1984;235-258.
14. Garcia K.C., Degano M., Speir J.A., Wilson I.A. Emerging principles for T cell receptor recognition of antigen in cellular immunity. Rev. Immunogenet. 1:1999;75-90.
15. Klein J., Figueroa F., Nagy Z.A. Genetics of the major histocompatibility complex: the final act. Annu. Rev. Immunol. 1:1983;119-142.
16. Nelson C.A., Fremont D.H. Structural principles of MHC class II antigen presentation. Rev. Immunogenet. 1:1999;47-59.
17. Parham P., Ohta T. Population biology of antigen presentation by MHC class I molecules. Science. 272:1996;67-74.
18. Cresswell P., Lanzavecchia A. Antigen processing and recognition. Curr. Opin. Immunol. 13:2001;11-12.
19. Jorgensen J.L., Esser U., Fazekas de St Groth B., Reay P.A., Davis M.M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 355:1992;224-230.
20. Sun R., Shepherd S.E., Geier S.S., Thomson C.T., Sheil J.M., Nathenson S.G. Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule. Immunity. 3:1995;573-582.
21. Sant'Angelo D.B., Waterbury G., Preston-Hurlburt P., Yoon S.T., Medzhitov R., Hong S.C., Janeway C.A. Jr. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity. 4:1996;367-376.
22. Garboczi D.N., Biddison W.E. Shapes of MHC restriction. Immunity. 10:1999;1-7.
23. Manning T.C., Kranz D.M. Binding energetics of T-cell receptors: correlation with immunological consequences. Immunol. Today. 20:1999;417-422.
24. Manning T.C., Parke E.A., Teyton L., Kranz D.M. Effects of complementarity determining region mutations on the affinity of an alpha/beta T cell receptor: measuring the energy associated with CD4/CD8 repertoire skewing. J. Exp. Med. 189:1999;461-470.
25. Manning T.C., Schlueter C.J., Brodnicki T.C., Parke E.A., Speir J.A., Garcia K.C., Teyton L., Wilson I.A., Kranz D.M. Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition. Immunity. 8:1998;413-425.
26. Matzinger P., Bevan M.J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29:1977;1-5.
27. Ignatowicz L., Winslow G., Bill J., Kappler J., Marrack P. Cell surface expression of class II MHC proteins bound by a single peptide. J. Immunol. 154:1995;3852-3862.
28. Miyazaki T., Wolf P., Tourne S., Waltzinger C., Dierich A., Barois N., Ploegh H., Benoist C., Mathis D. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 84:1996;531-541.
29. Zerrahn J., Held W., Raulet D.H. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell. 88:1997;627-636.
30. Grandea A.G. III, Bevan M.J. Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides. Proc. Natl. Acad. Sci. USA. 89:1992;2794-2798.
31. Davis M.M., Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature. 334:1988;395-402.
32. Bevan M.J. In thymic selection, peptide diversity gives and takes away. Immunity. 7:1997;175-178.
33. Hughes A.L., Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu. Rev. Genet. 32:1998;415-435.
34. Yeager M., Hughes A.L. Evolution of the mammalian MHC: natural selection, recombination, and convergent evolution. Immunol. Rev. 167:1999;45-58.
35. Nikolić-Žugić J., Bevan M.J. Role of self-peptides in positively selecting the T-cell repertoire. Nature. 344:1990;65-67.
36. Dyall R., Fremont D.H., Jameson S.C., Nikolić-Žugić J. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation. J. Exp. Med. 184:1996;253-258.
37. Dyall R., Messaoudi I., Janetzki S., Nikolić-Žugić J. MHC polymorphism can enrich the T cell repertoire of the species by shifts in intrathymic selection. J. Immunol. 164:2000;1695-1698.
38. Nikolić-Žugić J., Carbone F.R. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur. J. Immunol. 20:1990;2431-2437.
39. Rohren E.M., Pease L.R., Ploegh H.L., Schumacher T.N. Polymorphisms in pockets of major histocompatibility complex class I molecules influence peptide preference. J. Exp. Med. 177:1993;1713-1721.
40. Shimojo N., Anderson R.W., Mattson D.H., Turner R.V., Coligan J.E., Biddison W.E. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove. Int. Immunol. 2:1990;193-200.
41. Apanius V., Penn D., Slev P.R., Ruff L.R., Potts W.K. The nature of selection on the major histocompatibility complex. Crit. Rev. Immunol. 17:1997;179-224.
42. Bell J.I., Todd J.A., McDevitt H.O. The molecular basis of HLA-disease association. Adv. Hum. Genet. 18:1989;1-41.
43. Hill A.V. The genomics and genetics of human infectious disease susceptibility. Annu. Rev. Genom. Hum. Genet. 2:2001;373-400.
44. Parham P. Functional polymorphism in class I major histocompatibility complex genes. Soc. Gen. Physiol. Ser. 49:1994;93-103.
45. Hill A.V., Allsopp C.E., Kwiatkowski D., Anstey N.M., Twumasi P., Rowe P.A., Bennett S., Brewster D., McMichael A.J., Greenwood B.M. Common west African HLA antigens are associated with protection from severe malaria. Nature. 352:1991;595-600.
46. Gupta S., Hill A.V. Dynamic interactions in malaria: host heterogeneity meets parasite polymorphism. Proc. R. Soc. Lond. Biol. Sci. 261:1995;271-277.
47. Gilbert S.C., Plebanski M., Gupta S., Morris J., Cox M., Aidoo M., Kwiatkowski D., Greenwood B.M., Whittle H.C., Hill A.V. Association of malaria parasite population structure, HLA, and immunological antagonism. Science. 279:1998;1173-1177.
48. Gallina G., Cumbo V., Messina P., Caprera V., Lio D., Caruso C. Lack of correlation between HLA-B35 resistance against herpes labialis and antibody titers to HSV-1. Oral Surg. Oral Med. Oral Pathol. 68:1989;167-170.
49. Jeffery K.J., Usuku K., Hall S.E., Matsumoto W., Taylor G.P., Procter J., Bunce M., Ogg G.S., Welsh K.I., Weber J.N., Lloyd A.L., Nowak M.A., Nagai M., Kodama D., Izumo S., Osame M., Bangham C.R. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA. 96:1999;3848-3853.
50. Thursz M., Yallop R., Goldin R., Trepo C., Thomas H.C. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet. 354:1999;2119-2124.
51. Carrington M., Nelson G.W., Martin M.P., Kissner T., Vlahov D., Goedert J.J., Kaslow R., Buchbinder S., Hoots K., O'Brien S.J. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 283:1999;1748-1752.
52. Migueles S.A., Sabbaghian M.S., Shupert W.L., Bettinotti M.P., Marincola F.M., Martino L., Hallahan C.W., Selig S.M., Schwartz D., Sullivan J., Connors M. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA. 97:2000;2709-2714.
53. Hendel H., Caillat-Zucman S., Lebuanec H., Carrington M., O'Brien S., Andrieu J.M., Schachter F., Zagury D., Rappaport J., Winkler C., Nelson G.W., Zagury J.F. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J. Immunol. 162:1999;6942-6946.
54. O'Connor D.H., Mothe B.R., Weinfurter J.T., Fuenger S., Rehrauer W.M., Jing P., Rudersdorf R.R., Liebl M.E., Krebs K., Vasquez J., Dodds E., Loffredo J., Martin S., McDermott A.B., Allen T.M., Wang C., Doxiadis G.G., Montefiori D.C., Hughes A., Burton D.R., Allison D.B., Wolinsky S.M., Bontrop R., Picker L.J., Watkins D.I. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol. 77:2003;9029-9040.
55. Mothe B.R., Weinfurter J., Wang C., Rehrauer W., Wilson N., Allen T.M., Allison D.B., Watkins D.I. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 77:2003;2736-2740.
56. Kast W.M., Bronkhorst A.M., de Waal L.P., Melief C.J. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations. J. Exp. Med. 164:1986;723-738.
57. Messaoudi I., Guevara Patino J.A., Dyall R., LeMaoult J., Nikolich-Žugich J. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science. 298:2002;1797-1800.
58. Thursz M.R., Thomas H.C., Greenwood B.M., Hill A.V. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat. Genet. 17:1997;11-12.
59. Jeffery K.J.M., Siddiqui A.A., Bunce M., Lloyd A.L., Vine A.M., Witkover A.D., Izumo S., Usuku K., Welsh K.I., Osame M., Bangham C.R.M. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 165:2000;7278-7284.
60. McClelland E.E., Penn D.J., Potts W.K. Major histocompatibility complex heterozygote superiority during coinfection. Infect. Immun. 71:2003;2079-2086.
61. Penn D.J., Damjanovich K., Potts W.K. MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc. Natl. Acad. Sci. 2002;11260-11264. USA 99.
62. Allen P.M., Unanue E.R. Antigen processing and presentation at a molecular level. Adv. Exp. Med. Biol. 225:1987;147-154.
63. Buus S., Sette A., Colon S.M., Miles C., Grey H.M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 235:1987;1353-1358.
64. Yun T.J., Tallquist M.D., Rohren E.M., Sheil J.M., Pease L.R. Minor pocket B influences peptide binding, peptide presentation and alloantigenicity of H-2Kb. Int. Immunol. 6:1994;1037-1047.
65. Pullen J.K., Hunt H.D., Pease L.R. Peptide interactions with the Kb antigen recognition site. J. Immunol. 146:1991;2145-2151.
66. Hunt H.D., Pullen J.K., Dick R.F., Bluestone J.A., Pease L.R. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site. J. Immunol. 145:1990;1456-1462.
67. Rudolph M.G., Speir J.A., Brunmark A., Mattsson N., Jackson M.R., Peterson P.A., Teyton L., Wilson I.A. The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity. Immunity. 14:2001;231-242.
68. Messaoudi I., LeMaoult J., Nikolić-Žugić J. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies. J. Immunol. 163:1999;3286-3294.
69. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434-439.
70. Jeffery K.J., Siddiqui A.A., Bunce M., Lloyd A.L., Vine A.M., Witkover A.D., Izumo S., Usuku K., Welsh K.I., Osame M., Bangham C.R. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 165:2000;7278-7284.
71. Muhl T., Krawczak M., ten Haaft P., Hunsmann G., Sauermann U. MHC Class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 169:2002;3438-3446.
72. McMichael A.J., Gotch F.M., Santos-Aguado J., Strominger J.L. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 85:1988;9194-9198.
73. Shimojo N., Cowan E.P., Engelhard V.H., Maloy W.L., Coligan J.E., Biddison W.E. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73. J. Immunol. 143:1989;558-564.
74. Huard R., Dyall R., Nikolić-Žugić J. The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding. Int. Immunol. 9:1997;1701-1707.
75. Hogan K.T., Shimojo N., Walk S.F., Engelhard V.H., Maloy W.L., Coligan J.E., Biddison W.E. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide. J. Exp. Med. 168:1988;725-736.
76. Pullen J.K., Tallquist M.D., Melvold R.W., Pease L.R. Recognition of a single amino acid change on the surface of a major transplantation antigen is in the context of self peptide. J. Immunol. 152:1994;3445-3452.
77. Ajitkumar P., Geier S.S., Kesari K.V., Borriello F., Nakagawa M., Bluestone J.A., Saper M.A., Wiley D.C., Nathenson S.G. Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell. 54:1988;47-56.
78. Grandea A.G. III, Androlewicz M.J., Athwal R.S., Geraghty D.E., Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science. 270:1995;105-108.
79. Fremont D.H., Matsumura M., Stura E.A., Peterson P.A., Wilson I.A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science. 257:1992;919-927.
80. Franco A., Ferrari C., Sette A., Chisari F.V. Viral mutations, TCR antagonism and escape from the immune response. Curr. Opin. Immunol. 7:1995;524-531.
81. Itoh Y., Ogasawara K., Gotohda T., Takami K., Naruse H., Onoe K. A hole in the T cell repertoire specific for a pigeon cytochrome c related peptide associated with amino acid substitutions on I-Ab molecules. Int. Immunol. 4:1992;779-787.
82. Bhayani H.R., Hedrick S.M. The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire. J. Immunol. 146:1991;1093-1098.
83. Kaye J., Vasquez N.J., Hedrick S.M. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J. Immunol. 148:1992;3342-3353.